Publication | Closed Access
Clinical and Pharmacokinetic Phase I Study of Multitargeted Antifolate (LY231514) in Combination With Cisplatin
151
Citations
6
References
1999
Year
The combination of MTA and cisplatin is clinically active, and administering both agents on day 1 is superior to a split schedule. Further development of this combination for mesothelioma is warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1